4 years ago

Bactobio Secures $3.8 Million Seed Funding to Uncover Novel Solutions from Soil Bacteria

  • Bactobio, a London-based biotechnology company, has raised $3.8 million in seed funding

  • The company is developing a platform to culture the 99% of soil bacteria and uncover valuable secondary metabolites they produce

  • The funding will be used to accelerate the company's vision through stepping up automation across the pipeline and adding key members to the team

  • Backers include Peder Holk Nielsen (Former CEO & President, Novozymes), Leopoldo Zambeletti (Former Head of Healthcare, JP Morgan), Jonathan Milner (Founder, Abcam) and Claudio Costamagna (Former Chairman, Goldman Sachs, EMEA), and Hugh Grant (Former Chairman & CEO, Monsanto).

      • ProblemBiotechnology

      "developing new solutions for healthcare, agriculture, and industrials markets by discovering novel compounds from previously unculturable soil bacteria"

      Solution

      "using a proprietary technology platform that combines microbiology, bioinformatics, and machine learning to culture the 99% of soil bacteria and uncover valuable secondary metabolites"

      Covered on